Join us for an insightful webinar to discuss a holistic approach to testing for TB in a clinical setting. Tuberculosis remains a global health challenge, with significant hurdles in diagnosing and ...
February 6, 2012 — Cases of multidrug-resistant tuberculosis (MDR-TB) hit an all-time high worldwide in 2009 and 2010, with 1 country reporting multidrug resistance in 65.1% of all previously treated ...
FRANKLIN LAKES, N.J., April 13, 2021 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that its BD MAXTM Molecular Multi-Drug ...
In a significant boost to India’s tuberculosis (TB) eradication efforts, Mumbai has achieved a major success in the fight ...
A new partnership announced today will increase efforts to coordinate the development of complementary novel tools to fight TB, including drug-resistant TB, and identify emerging drug resistance ...
More than 10 million people fall sick with tuberculosis (TB) every year. The disease remains the world’s biggest infectious disease killers with an estimated 1.25 million annual deaths. The disease is ...
In a recent review published in the Open Forum Infectious Diseases journal, researchers reported on the evolution of multidrug-resistant tuberculosis (MDR-TB) therapy. Study: At long last: short, ...
Despite global efforts, multidrug-resistant tuberculosis in children is rising at an alarming rate, with younger children at the highest risk of mortality—urgent action is needed to reverse the trend.
IPC to develop IP Reference Standards for anti-TB medicine bedaquiline: Shardul Nautiyal, Mumbai Thursday, January 22, 2026, 08:00 Hrs [IST] In order to ensure quality and safe an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback